Headline News

 

Sanofi launches €3 million Planet Mobilization fund to support employees’ environmental projects

Posted on June 08, 2021

Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients

Posted on June 08, 2021

Moderna and Medison Pharma Partner to Commercialize Moderna’s COVID-19 Vaccine Across Central Eastern Europe and Israel

Posted on June 08, 2021

Moderna Files for Authorization with Health Canada for its COVID-19 Vaccine in Adolescents

Posted on June 08, 2021

Kite’s Tecartus® Earns Priority Review Designation Demonstrates High Response Rate in Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

Posted on June 08, 2021

Imfinzi demonstrated unprecedented survival in unresectable, Stage III lung cancer with 43% of patients surviving five years

Posted on June 08, 2021

Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus Infection

Posted on June 08, 2021

Statement on the SAGE Recommendation Regarding the J&J Ebola Vaccine Regimen

Posted on June 08, 2021

Janssen Affiliate Cilag GmbH International Discontinues Collaboration and License Agreement with argenx for Cusatuzumab

Posted on June 08, 2021

Novartis announces iptacopan met Phase II study primary endpoint in rare kidney disease IgA nephropathy

Posted on June 08, 2021

Updated Data Demonstrate Significant Improvement in Hematologic Complete Response with DARZALEX FASPRO® in Patients with Newly Diagnosed Light Chain (AL) Amyloidosis

Posted on June 01, 2021

Sanofi provides update on venglustat clinical program

Posted on June 01, 2021

US FDA Seeks to Further Investments in Critical Public Health Infrastructure, Core Food Safety and Medical Product Safety Programs

Posted on June 01, 2021

Moderna at Fourth Annual Science Day Highlights Advances in Platform Science and Innovative Vaccine Research

Posted on June 01, 2021

GSK to showcase at ASCO and EHA in scientific advances and progress in oncology

Posted on June 01, 2021